NAFDAC bans unregistered Tarivid batch over safety concerns
The National Agency for Food and Drug Administration and Control (NAFDAC) has banned an unregistered batch of the antibacterial drug Tarivid (Ofloxacin 200mg), citing serious safety concerns after the product was discovered circulating within Nigeria’s healthcare supply chain. In a
Guardian Nigeria
Read More
Follow Us on Google News